Tuesday, March 17, 2026

Trump’s Next Deal: Kim Jong Un Demands a Nuclear Summit, Bypassing South Korea

Kim Jong Un's speech signals a potential shift in U.S.-North Korea relations, emphasizing dialogue while excluding South Korea.

President Yoon’s G20 Agenda: A Focus on Ending Hunger and Climate Change

South Korean President Yoon Suk Yeol heads to Brazil for the G20 Summit, focusing on hunger eradication and sustainable development.

North Korea’s Ambitious Plans: Healthcare, Education, and Local Industry in Focus

North Korea held meetings to implement decisions from last month's session, focusing on local development and healthcare improvements.

Tag: FDA approval

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

J&J Aims to Treat Cancer Before It Starts Showing Symptoms

Johnson & Johnson leads in multiple myeloma treatment, pioneering early intervention for high-risk patients with a new subcutaneous formulation.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.